AEON Biopharma, Inc. (AEON)
(Delayed Data from AMEX)
$1.38 USD
-0.40 (-22.47%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.53 +0.15 (10.87%) 7:28 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
AEON Biopharma, Inc. [AEON]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: AEON Biopharma, Inc.
Industry: Unclassified
Alignment With FDA Charts Path Forward in Chronic and Episodic Migraine; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
ABP-450 Shows Impressive Effect in Treating Episodic Migraine
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
Aeon Looks Poised to Disrupt the Blockbuster Neurotoxin Market; Initiate at Buy With $18 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|